Literature DB >> 21656027

The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma.

Jun Huang1, Yuan Qiu, Guoqin Chen, Liyan Huang, Jianxing He.   

Abstract

This study aimed to investigate the expression of Bmi-1 in lung squamous cell carcinoma tissues and the relationship between Bmi-1 and the epithelial-mesenchymal transition. RT-PCR and western blot analysis were performed to detect the expression of Bmi-1, E-cadherin, and Vimentin in 56 cases of lung squamous cell carcinoma tissues and adjacent normal tissues. The positive rates of Bmi-1, E-cadherin, and Vimentin mRNA expression in lung squamous cell carcinoma tissues were 73.2, 42.9, and 58.9%, respectively; compared to the expression of these genes in adjacent normal tissues (14.3, 75.0, and 28.6%), the differences were significant (P < 0.05). The expression of Bmi-1 in lung squamous cell carcinoma tissues showed a negative correlation with that of E-cadherin (r = -0.372, P = 0.005) and a positive correlation with that of Vimentin (r = 0.315, P = 0.02). The expression of Bmi-1 and Vimentin mRNA and protein in lung squamous cell carcinoma tissues was significantly higher than that in adjacent normal tissues (P < 0.05), and the expression of Bmi-1 and Vimentin in patients with lymph node and distal metastasis was significantly higher than that in patients without lymph node and distal metastasis (P < 0.05). The expression of E-cadherin mRNA and protein in lung squamous cell carcinoma tissues was significantly lower than that in adjacent normal tissues (P < 0.05), and the expression in patients with lymph node and distal metastasis was significantly lower than that in patients without lymph node and distal metastasis (P < 0.05). The expression of Bmi-1, E-cadherin, and Vimentin was not associated with the patient's sex, age, tumor size or degree of tumor differentiation (P > 0.05). The increase in Bmi-1 expression was accompanied by the down-regulation of E-cadherin expression and up-regulation of Vimentin expression. Bmi-1 may be associated with the epithelial-mesenchymal transition in lung squamous cell carcinoma and the occurrence, invasion, and metastasis of lung squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656027     DOI: 10.1007/s12032-011-9998-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  39 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds.

Authors:  Pierre A Coulombe; Pauline Wong
Journal:  Nat Cell Biol       Date:  2004-08       Impact factor: 28.824

3.  Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice.

Authors:  Y Haupt; W S Alexander; G Barri; S P Klinken; J M Adams
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

4.  Epithelial mesenchymal transition and lung cancer.

Authors:  Dakai Xiao; Jianxing He
Journal:  J Thorac Dis       Date:  2010-09       Impact factor: 2.895

Review 5.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

6.  Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

Authors:  Anwar B Beshir; Gang Ren; Anniefer N Magpusao; Lauren M Barone; Kam C Yeung; Gabriel Fenteany
Journal:  Cancer Lett       Date:  2010-09-19       Impact factor: 8.679

7.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

8.  The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit.

Authors:  Kimberly Lin; Stavroula Baritaki; Loredana Militello; Graziella Malaponte; Ylenia Bevelacqua; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2010-05

9.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

Review 10.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

View more
  13 in total

Review 1.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

2.  Plasma Bmi1 mRNA as a potential prognostic biomarker for distant metastasis in colorectal cancer patients.

Authors:  Jason Chun-Sang Pun; Joyce Yee-Jing Chan; Bobby Ka-Ming Chun; Ka-Wai Ng; Samuel Yung-Kin Tsui; Timothy Ming-Hun Wan; Oswens Lo; Jensen Tung-Chung Poon; Lui Ng; Roberta Pang
Journal:  Mol Clin Oncol       Date:  2014-06-20

3.  BMI-1, a promising therapeutic target for human cancer.

Authors:  Min-Cong Wang; Chun-Li Li; Jie Cui; Min Jiao; Tao Wu; L I Jing; Ke-Jun Nan
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

Review 4.  Context-dependent actions of Polycomb repressors in cancer.

Authors:  M Koppens; M van Lohuizen
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

5.  miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver.

Authors:  Hong-Yuan Chen; Zhong-Bo Han; Jun-Wei Fan; Jun Xia; Jun-Yi Wu; Guo-Qiang Qiu; Hua-Mei Tang; Zhi-Hai Peng
Journal:  Med Oncol       Date:  2011-07-24       Impact factor: 3.064

6.  Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.

Authors:  Anchalee Techasen; Nisana Namwat; Watcharin Loilome; Pornpan Bungkanjana; Narong Khuntikeo; Anucha Puapairoj; Patcharee Jearanaikoon; Hideyuki Saya; Puangrat Yongvanit
Journal:  Med Oncol       Date:  2012-08-19       Impact factor: 3.064

Review 7.  The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Authors:  Kristine Raaby Jakobsen; Christina Demuth; Boe Sandahl Sorensen; Anders Lade Nielsen
Journal:  Transl Lung Cancer Res       Date:  2016-04

8.  Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer.

Authors:  Fariz Nurwidya; Fumiyuki Takahashi; Akiko Murakami; Kazuhisa Takahashi
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

9.  A novel autoantibody test for the detection of pre-neoplastic lung lesions.

Authors:  Frazer J Lowe; Weike Shen; Jinchi Zu; Junfu Li; Hao Wang; Xufei Zhang; Li Zhong
Journal:  Mol Cancer       Date:  2014-04-05       Impact factor: 27.401

10.  Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.

Authors:  Min-Cong Wang; Min Jiao; Tao Wu; Li Jing; Jie Cui; Hui Guo; Tao Tian; Zhi-ping Ruan; Yong-Chang Wei; Li-Li Jiang; Hai-Feng Sun; Lan-Xuan Huang; Ke-Jun Nan; Chun-Li Li
Journal:  Oncotarget       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.